TP53 and cancer: Notably, 393P lung adenocarcinoma cells (similarly harboring Kras and p53 mutations) were not as sensitive to 3-MA as cancer cells of pancreatic origin and only exhibited proliferation attenuation at the highest 3-MA dose tested (Figure 4A).